CASPR Biotech

Diagnostics powered by mimetic CRISPR

Team

Franco Goytia

CEO & Co-Founder

Lucia Curti

Co-Founder

Carla Gimenez

Co-Founder

Company details

Caspr.bio has a COVID-19 test leveraging the CRISPR Cas-12 enzyme that is cheap and rapid, at point of care. The San Francisco and Buenos Aires-based company started 2 years ago, went through IndieBio, and originally worked on Zika virus and other genetic testing. Caspr’s methodology delivers positive tests results very quickly after RNA extraction (1 hour vs. 8+ hours or days in some instances), using devices that cost less than $200 and testing strips that cost less than $10. Because the tests do not require a lab to process, they can be administered in public places such as train stations, business lobbies and airports. Once approved by the FDA, Caspr’s test will be the first CRISPR-approved COVID-19 diagnostic test. The company has working prototypes, plans to scale production over the next 2 months and start commercial testing at hospitals and labs in New York soon.

Get In Touch with CASPR Biotech

Please tell us a little bit about yourself and why you'd like to get connected. CASPR Biotech + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.